Addressing key questions with statin therapy
Toth, P.P.
Journal of Family Practice 61(6 Suppl): S34-S39
2012
ISSN/ISBN: 0094-3509 PMID: 22670245 Document Number: 663830
Document emailed within 1 workday
Related Documents
Christensen, D.B. 2000: DUR: asking and addressing relevant policy questions Journal of the American Pharmaceutical Association 40(6): 709-710Munn, Z.; Moola, S.; Riitano, D.; Lisy, K. 2014: The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence International Journal of Health Policy and Management 3(3): 123-128
McCain, J. 2004: Statin therapy: more than meets the eye? Managed Care 13(4): 40-49
Clem, J.R. 1996: Improved survival with statin therapy South Dakota Journal of Medicine 49(8): 273-274
Keller, K.B.; Lemberg, L. 2005: Statin therapy in congestive heart failure American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 14(4): 338-340
Enas, E.A.; Pazhoor, H.C.; Kuruvila, A.; Vijayaraghavan, K. 2011: Intensive statin therapy for Indians: Part-I. Benefits Indian Heart Journal 63(3): 211-227
Langer, A.; Constance, C.; Fodor, J.G.; Frohlich, J.J.; Grégoire, J.; Lau, D.C.W.; Leiter, L.A.; Mancini, G.B.John.; Marr, D.; McPherson, R.; O'Neill, B.J.; Rabkin, S.W. 2003: Statin therapy and the management of acute coronary syndromes Canadian Journal of Cardiology 19(8): 921-927
2003: After several years of statin therapy. Long-term prevention of cardiac death MMW Fortschritte der Medizin 145(8): 56
Seeger, H.; Wallwiener, D.; Mueck, A.O. 2000: Additive antioxidative effect of hormone replacement therapy combined with a statin Clinical and Experimental Obstetrics and Gynecology 27(3-4): 179-181
Li, X.; Liu, X.-p.; Liu, X.-h.; Du, X.; Kang, J.-p.; Lü, Q.; Wang, H.-y.; Xu, X.; Liang, C.; Yan, Q.; Lei, T.; Geng, L.-l.; Liu, B.-q.; Ma, C.-s. 2010: Effect of statin therapy on mortality in patients with non-ischemic dilated cardiomyopathy Zhonghua Yi Xue Za Zhi 90(28): 1974-1977
Liu, L-Ping.; Wang, Y-Jun. 2011: Strengthening the role of statin therapy in atherosclerosis for the prevention and treatment of cerebrovascular disease Zhonghua Nei Ke Za Zhi 50(4): 275-277
Håkansson, J. 2011: Strengthened support for statin therapy as secondary prevention. Doubtful evidence for more intensive lowering of cholesterol levels Lakartidningen 108(22-23): 1234-1235
Chyrchel, M.ł; Dudek, D.; Bartuś, S.ła.; Legutko, J.; Heba, G.; Dubiel, J.S. 2004: High-dose statin and COX-2 inhibitor therapy rapidly decreases C-reactive protein level in patients with unstable angina Kardiologia Polska 61(9): 213-221; Discussion: 222-224
Konstantinov, V.O. 2017: The Role of non-Statin Therapy for Lowering the Concentration of low-Density Lipoprotein Cholesterol and Reducing the Risk of Developing Atherosclerotic Cardiovascular Complications Kardiologiia 57(5): 68-72
Kłosiewicz-Latoszek, L.; Respondek, W.; Białobrzeska-Paluszkiewicz, J.; Grzybowska, B.; Jakóbisiak-Ostasz, B.; Stolarska, I. 2003: Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 15(85): 42-46
Cervia, J.S. 2016: Addressing the Needs of Youth With HIV Infection in the Era of Combination Antiretroviral Therapy Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 62(7): 947
Homer, C.S.E.; Castro Lopes, S.; Nove, A.; Michel-Schuldt, M.; McConville, F.; Moyo, N.T.; Bokosi, M.; Ten Hoope-Bender, P. 2018: Barriers to and strategies for addressing the availability, accessibility, acceptability and quality of the sexual, reproductive, maternal, newborn and adolescent health workforce: addressing the post-2015 agenda Bmc Pregnancy and Childbirth 18(1): 55
Homer, C.S.E.; Castro Lopes, S.; Nove, A.; Michel-Schuldt, M.; McConville, F.; Moyo, N.T.; Bokosi, M.; Ten Hoope-Bender, P. 2018: Barriers to and strategies for addressing the availability, accessibility, acceptability and quality of the sexual, reproductive, maternal, newborn and adolescent health workforce: addressing the post-2015 agenda Bmc Pregnancy and Childbirth 18(1): 55
Sergienko, I.V.; Semenova, A.E.; Masenko, V.P.; Ezhov, M.V.; Gabrusenko, S.A.; Kukharchuk, V.V.; Belenkov, I.N. 2007: Effect of statin therapy on dynamics of vascular endothelial growth factor and fibroblast growth factor in patients with ischemic heart disease Kardiologiia 47(8): 4-7
Geller, S.L. 1986: Questions on chelation therapy Journal of the Florida Medical Association 73(12): 921-922